LSHTM Research Online

Jensen, ATR; Magistrado, P; Sharp, S; Joergensen, L; Lavstsen, T; Chiucciuini, A; Salanti, A; Vestergaard, LS; Lusingu, JP; Hermsen, R; Sauerwein, R; Christensen, J; Nielsen, MA; Hviid, L; Sutherland, CJ; Staalsoe, T; Theander, TG; (2004) Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. The Journal of experimental medicine, 199 (9). p. 1179. ISSN 0022-1007 DOI: 10.1084/jem.20040274

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (371Kb) | Preview

Abstract

Parasite-encoded variant surface antigens (VSAs) like the var gene-encoded Plasmodium falciparum erythrocyte membrane protein 1 (PfFMP1) family are responsible for antigenic variation and infected red blood cell (RBC) cytoadhesion in P.falciparum malaria. Parasites causing severe malaria in nonimmune patients tend to express a restricted subset of VSA (VSA(SM)) that differs from VSA associated With uncomplicated malaria and asymptomatic Infection (VSA(UM)). We compared var gene transcription in unselected P. falciparum clone 3D7 expressiring VSA(UM) to in vitro-selected sublines expressing VSA(SM) to identify PfEMP1 responsible for the VSA,, phenotype. Expression of VSA(SM) Was accompanied by up-regulation of Group A var genes. The most prominently up-regulated Group A gene (PFD1235u/MAL7P1.1) was translated into a protein expressed oil the infected RBC surface. The proteins encoded by Group A var genes, such as PFD1233w/MAL7P1.1, appear to be involved in the pathogenesis of severe disease and are thus attractive candidates for a vaccine against life-threatening P.falciparum malaria.

Actions (login required)